959648133	959648133	CD	B-NP	O
|	|	NN	I-NP	O
MAH	MAH	NN	I-NP	O
|	|	NN	I-NP	O
90934547	90934547	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2222541	2222541	CD	B-NP	O
|	|	CC	I-NP	O
4/5/2003	4/5/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
PREGNANCY	PREGNANCY	NN	I-NP	O
,	,	,	O	O
371/2	371/2	CD	B-NP	O
WEEKS	WEEKS	NNP	I-NP	O
,	,	,	O	O
HYPERTENSION	HYPERTENSION	NNP	B-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2003	11/10/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/27/2003	10/27/2003	CD	B-NP	O
Date	Date	NNP	I-NP	O
of	of	IN	B-PP	O
Discharge	Discharge	NNP	B-NP	O
:	:	:	O	O
10/27/2003	10/27/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BRADY	BRADY	NNP	B-NP	O
FOLLAND	FOLLAND	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ATTENDING	ATTENDING	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Dane	Dane	NNP	B-NP	O
Goodaker	Goodaker	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Type	Type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
preeclampsia	preeclampsia	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
primary	primary	JJ	B-NP	O
cesarean	cesarean	JJ	I-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
42-year-old	42-year-old	JJ	I-NP	O
,	,	,	I-NP	O
G3	G3	NN	I-NP	O
,	,	,	I-NP	O
P0	P0	NN	I-NP	B-DNA
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Labor	Labor	NN	B-NP	O
and	and	CC	I-NP	O
Delivery	Delivery	NN	I-NP	O
on	on	IN	B-PP	O
11/10/2003	11/10/2003	CD	B-NP	O
at	at	IN	B-PP	O
32-4/7	32-4/7	CD	B-NP	O
weeks	week	NNS	I-NP	O
gestation	gestation	NN	I-NP	O
,	,	,	O	O
dated	date	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
7-week	7-week	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
with	with	IN	B-PP	O
class	class	NN	B-NP	O
B	B	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
headaches	headache	NNS	B-NP	O
,	,	,	O	O
visual	visual	JJ	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
epigastric	epigastric	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
report	report	VB	I-VP	O
a	a	DT	B-NP	O
16-pound	16-pound	JJ	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
4	4	CD	B-NP	I-protein
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
on	on	IN	B-PP	O
urine	urine	NN	B-NP	O
dip	dip	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
class	class	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
diabetes	diabete	VBZ	B-VP	O
mellitus	mellitus	NN	B-NP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
prenatal	prenatal	JJ	I-NP	O
screens	screen	NNS	I-NP	O
are	be	VBP	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
Rh	Rh	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
antibody	antibody	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
RPR	RPR	NN	B-NP	B-protein
nonreactive	nonreactive	JJ	I-NP	O
,	,	,	I-NP	O
Gonorrhea	Gonorrhea	NNP	I-NP	O
and	and	CC	I-NP	O
Chlamydia	Chlamydia	NNP	I-NP	O
negative	negative	JJ	I-NP	O
,	,	,	I-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
electrophoresis	electrophoresis	NN	I-NP	O
AA	AA	NN	I-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
surface	surface	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
TSH	TSH	NN	B-NP	O
was	be	VBD	B-VP	O
2.02	2.02	CD	B-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
A1C	A1C	NN	I-NP	O
on	on	IN	B-PP	O
9/28/2002	9/28/2002	CD	B-NP	O
was	be	VBD	B-VP	O
8.7	8.7	CD	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
3/2/2002	3/2/2002	CD	B-NP	O
was	be	VBD	B-VP	O
9.4	9.4	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
chorionic	chorionic	JJ	I-NP	B-DNA
villus	villus	NN	I-NP	I-DNA
sampling	sample	VBG	B-VP	I-DNA
procedure	procedure	NN	B-NP	I-DNA
revealing	reveal	VBG	B-VP	I-DNA
normal	normal	JJ	B-NP	I-DNA
chromosomes	chromosome	NNS	I-NP	I-DNA
.	.	.	O	O

As	As	IN	B-SBAR	O
stated	state	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
dated	date	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
7-week	7-week	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
current	current	JJ	I-NP	O
pregnancy	pregnancy	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Shelton	Shelton	NNP	I-NP	O
Reges	Reges	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
from	from	IN	B-PP	O
8	8	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
gestation	gestation	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
prenatal	prenatal	JJ	I-NP	O
course	course	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
122/70	122/70	CD	B-NP	O
,	,	,	O	O
range	range	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
was	be	VBD	B-VP	O
100/60	100/60	CD	B-NP	O
to	to	TO	B-PP	O
130/80	130/80	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
medications	medication	NNS	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
158/90	158/90	CD	B-NP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
on	on	IN	B-PP	O
dip	dip	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
signs	sign	NNS	B-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
preeclampsia	preeclampsia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
second	second	JJ	I-NP	O
prenatal	prenatal	JJ	I-NP	O
issue	issue	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
B	B	NN	I-NP	O
type2	type2	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
hemoglobin	hemoglobin	NN	I-NP	O
A1C	A1C	NN	I-NP	O
was	be	VBD	B-VP	O
6.6	6.6	CD	B-NP	O
on	on	IN	B-PP	O
2/2/2003	2/2/2003	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
24-hour	24-hour	JJ	I-NP	O
urine	urine	NN	I-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
59	59	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
good	good	JJ	B-NP	O
fetal	fetal	JJ	I-NP	O
growth	growth	NN	I-NP	O
on	on	IN	B-PP	O
ultrasound	ultrasound	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
a	a	DT	B-NP	O
25-week	25-week	JJ	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
fetal	fetal	JJ	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
973	973	CD	B-NP	O
g	g	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
91st	91st	JJ	I-NP	O
percentile	percentile	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
survey	survey	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
28	28	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
fetus	fetus	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
370	370	CD	B-NP	O
g	g	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
86th	86th	JJ	I-NP	O
percentile	percentile	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
Dopplers	Doppler	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
32	32	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
fetus	fetus	NN	I-NP	O
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
,	,	,	O	O
976	976	CD	B-NP	O
g	g	NN	I-NP	O
on	on	IN	B-PP	O
11/10/2003	11/10/2003	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
66th	66th	JJ	I-NP	O
percentile	percentile	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
anterior	anterior	JJ	B-NP	O
placenta	placenta	NN	I-NP	O
,	,	,	O	O
vertex	vertex	NN	B-NP	O
position	position	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
Dopplers	Doppler	NNS	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
survey	survey	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
third	third	JJ	I-NP	O
issue	issue	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
was	be	VBD	B-VP	O
morbid	morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
BMI	BMI	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fourth	fourth	JJ	I-NP	O
issue	issue	NN	I-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
maternal	maternal	JJ	B-NP	O
age	age	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
chorionic	chorionic	JJ	I-NP	O
villus	villus	NN	I-NP	O
sampling	sampling	NN	I-NP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
chromosomes	chromosome	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
diagnosed	diagnose	VBD	B-VP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
glyburide	glyburide	NN	I-NP	O
until	until	IN	B-PP	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
pregnant	pregnant	JJ	B-ADJP	O
and	and	CC	O	O
then	then	RB	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Excision	Excision	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
facial	facial	JJ	I-NP	O
sebaceous	sebaceous	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
,	,	,	O	O
therapeutic	therapeutic	JJ	B-NP	O
abortion	abortion	NN	I-NP	O
x	x	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
OB	OB	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
G3	G3	NN	B-NP	O
,	,	,	O	O
P0020	P0020	NN	B-NP	B-protein
.	.	.	O	O

Therapeutic	Therapeutic	JJ	B-NP	O
TAB	TAB	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
therapeutic	therapeutic	JJ	B-NP	O
TAB	TAB	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
NPH	NPH	NN	B-NP	O
and	and	CC	I-NP	O
Humalog	Humalog	NN	I-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
regimen	regimen	NN	B-NP	O
adjusted	adjust	VBD	B-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
and	and	CC	O	O
prenatal	prenatal	JJ	B-NP	O
vitamins	vitamin	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/80	160/80	CD	B-NP	O
,	,	,	O	O
afebrile	afebrile	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
and	and	CC	I-NP	O
gravid	gravid	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
deep	deep	JJ	I-NP	O
tendon	tendon	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
.	.	.	O	O

Fetal	Fetal	JJ	B-NP	O
heart	heart	NN	I-NP	O
tones	tone	NNS	I-NP	O
were	be	VBD	B-VP	O
140s	140s	CD	B-NP	O
and	and	CC	O	O
reactive	reactive	JJ	B-NP	O
,	,	,	I-NP	O
vertex	vertex	NN	I-NP	O
position	position	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
fetus	fetus	NN	I-NP	O
by	by	IN	B-PP	O
Leopold	Leopold	NNP	B-NP	O
and	and	CC	O	O
ultrasound	ultrasound	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Labor	Labor	NN	B-NP	O
and	and	CC	I-NP	O
Delivery	Delivery	NN	I-NP	O
for	for	IN	B-PP	O
rule	rule	NN	B-NP	O
out	out	IN	B-PP	O
preeclampsia	preeclampsia	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
laboratory	laboratory	NN	I-NP	O
studies	study	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
0.8	0.8	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
323	323	CD	B-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
39	39	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
uric	uric	JJ	B-NP	O
acid	acid	NN	I-NP	O
5.6	5.6	CD	I-NP	O
,	,	,	O	O
24-hour	24-hour	JJ	B-NP	O
urine	urine	NN	I-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
2	2	CD	B-NP	O
,	,	,	O	O
995	995	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
labor	labor	NN	I-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
ruling	ruling	NN	B-NP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
preeclampsia	preeclampsia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
magnesium	magnesium	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
seizure	seizure	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
betamethasone	betamethasone	NN	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
lung	lung	NN	I-NP	O
maturity	maturity	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
watched	watch	VBN	I-VP	O
carefully	carefully	RB	B-ADVP	O
after	after	IN	B-SBAR	O
the	the	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
betamethasone	betamethasone	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
betamethasone	betamethasone	NN	B-NP	O
complete	complete	JJ	B-ADJP	O
on	on	IN	B-PP	O
1/24/2003	1/24/2003	CD	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
labor	labor	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
using	use	VBG	I-VP	O
cervical	cervical	JJ	B-NP	O
ripening	ripen	VBG	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
Cervidil	Cervidil	NN	B-NP	B-protein
x	x	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
Cytotec	Cytotec	NNP	B-NP	B-protein
x	x	NNP	I-NP	I-protein
4	4	CD	I-NP	I-protein
,	,	,	O	O
Foley	Foley	NNP	B-NP	O
bulb	bulb	NN	I-NP	O
mechanical	mechanical	JJ	I-NP	O
dilatation	dilatation	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
Pitocin	Pitocin	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
reached	reach	VBD	B-VP	O
1	1	CD	B-NP	O
cm	cm	NN	I-NP	O
dilatation	dilatation	NN	I-NP	O
,	,	,	O	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
effacement	effacement	NN	I-NP	O
,	,	,	O	O
-3	-3	CD	B-NP	O
station	station	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
on	on	IN	B-PP	O
5/2/2003	5/2/2003	CD	B-NP	O
,	,	,	O	O
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
failure	failure	NN	I-NP	O
of	of	IN	B-PP	O
initiating	initiate	VBG	B-VP	O
labor	labor	NN	B-NP	O
with	with	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
ripening	ripening	NN	I-NP	O
agents	agent	NNS	I-NP	O
and	and	CC	O	O
Foley	Foley	NNP	B-NP	O
bulb	bulb	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
proceed	proceed	VB	I-VP	O
with	with	IN	B-PP	O
laminaria	laminaria	NN	B-NP	O
to	to	TO	B-VP	O
mechanically	mechanically	RB	I-VP	O
dilate	dilate	VB	I-VP	O
the	the	DT	B-NP	O
cervix	cervix	NN	I-NP	O
further	further	RBR	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
5/2/2003	5/2/2003	CD	B-NP	O
,	,	,	O	O
28	28	CD	B-NP	O
laminaria	laminaria	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cervix	cervix	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Pitocin	Pitocin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
laminaria	laminaria	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
3-4	3-4	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
station	station	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Pitocin	Pitocin	NN	B-NP	O
for	for	IN	B-PP	O
protocol	protocol	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
cervix	cervix	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
consented	consent	VBN	I-VP	O
for	for	IN	B-PP	O
cesarean	cesarean	JJ	B-NP	O
section	section	NN	I-NP	O
for	for	IN	B-PP	O
failure	failure	NN	B-NP	O
to	to	TO	B-VP	O
progress	progress	VB	I-VP	O
with	with	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
labor	labor	NN	B-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
preeclampsia	preeclampsia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
remained	remain	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
regards	regard	NNS	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
preeclampsia	preeclampsia	NN	I-NP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/25/2003	3/25/2003	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
primary	primary	JJ	I-NP	O
cesarean	cesarean	JJ	I-NP	O
section	section	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
transverse	transverse	NN	I-NP	O
for	for	IN	B-PP	O
delivery	delivery	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
3	3	CD	I-NP	O
pound	pound	NN	I-NP	O
7	7	CD	B-NP	O
ounce	ounce	NN	I-NP	O
vigorous	vigorous	JJ	I-NP	O
infant	infant	NN	I-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
35	35	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
,	,	,	O	O
3/25/2003	3/25/2003	CD	B-NP	O
.	.	.	O	O

Apgars	Apgar	NNS	B-NP	O
were	be	VBD	B-VP	O
7	7	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
minute	minute	NN	I-NP	O
and	and	CC	O	O
8	8	CD	B-NP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
JP	JP	NN	I-NP	B-protein
drain	drain	NN	I-NP	I-protein
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
morbid	morbid	JJ	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
postpartum	postpartum	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
restarting	restart	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
antihypertensives	antihypertensive	NNS	I-NP	O
and	and	CC	O	O
continuing	continue	VBG	B-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
and	and	CC	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Humalog	Humalog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Jackson-Pratt	Jackson-Pratt	JJ	I-NP	O
drain	drain	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	I-NP	O
staples	staple	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
Visiting	Visiting	NNP	B-NP	O
Nurse	Nurse	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
followup	followup	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Spencer	Spencer	NNP	I-NP	O
Jensrud	Jensrud	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
prenatal	prenatal	JJ	B-NP	O
vitamins	vitamin	NNS	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
1-2	1-2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Niferex	Niferex	NNP	B-NP	O
one	one	CD	I-NP	O
capsule	capsule	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
checked	check	VBN	B-VP	O
by	by	IN	B-PP	O
Visiting	Visit	VBG	B-VP	O
Nurse	Nurse	NNP	B-NP	O
Services	Services	NNP	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
show	show	VB	I-VP	O
these	these	DT	B-NP	O
sugar	sugar	NN	I-NP	O
values	value	NNS	I-NP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Elliott	Elliott	NNP	I-NP	O
Quatrevingt	Quatrevingt	NNP	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tyree	Tyree	NNP	I-NP	O
Landers	Landers	NNP	I-NP	O
in	in	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
staple	staple	NN	B-NP	O
removal	removal	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
nothing	nothing	NN	B-NP	O
per	per	IN	B-PP	O
vagina	vagina	NN	B-NP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tampons	tampon	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sexual	sexual	JJ	I-NP	O
intercourse	intercourse	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
douching	douching	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
lifting	lifting	NN	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
for	for	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
heavy	heavy	JJ	B-NP	O
vaginal	vaginal	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
concerns	concern	NNS	I-NP	O
about	about	IN	B-PP	O
her	her	PRP$	B-NP	O
incision	incision	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
UPON	UPON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	B-protein
86	86	CD	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
141	141	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.6	4.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
20	20	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
92	92	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.3	0.3	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
of	of	IN	B-PP	O
9.2	9.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
29.9	29.9	CD	I-NP	I-protein
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-4373647	2-4373647	CD	B-NP	O
TFFocus	TFFocus	NN	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
VANLANDINGHAM	VANLANDINGHAM	NNP	B-NP	O
,	,	,	O	O
AMOS	AMOS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DANG	DANG	NNP	B-NP	O
,	,	,	O	O
FRANKLIN	FRANKLIN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0620620	0620620	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/13/03	10/13/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/23/03	1/23/03	CD	B-NP	O

